oleclumab,durvalumab
AstraZeneca
['vance', 'durva', 'oleclumab', 'tnbc', 'bcsm']
oleclumab/durvalumab plus chemotherapy combo fails to reach clinical benefit end point in advanced tnbc #esmo2022 #bcsm 
Healthcare publisher of oncology focused articles, videos, panel discussions, and much more that run the gamut of oncology care and management.